Hong Kong Pharma Digital Technology Holdings Ltd

Research Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) on Bullrun: market cap USD 9.35M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 9.35M.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 9.35Mn/an/an/a
20252025-12-31USD 9.02Mn/an/an/a

About Hong Kong Pharma Digital Technology Holdings Ltd

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Hong Kong Pharma Digital Technology Holdings Ltd's market cap?

Hong Kong Pharma Digital Technology Holdings Ltd's market capitalization is USD 9.35M.

What does Hong Kong Pharma Digital Technology Holdings Ltd do?

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides value-added services such as labeling, extended storage, product inspection, batch processing, and logistics support, as well as sales of health supplements and non-pharmaceutical products.